摘要
目的探讨一次性输血器在肝硬化顽固性腹水中的治疗价值。方法将64例肝硬化顽固性腹水患者随机分为观察组(32例)和对照组(32例),观察组患者采用一次性输血器穿刺法引流腹水,对照组患者采用传统腹腔穿刺法排放腹水。对比两组患者治疗后的临床疗效、临床指标和生化指标。结果治疗后,两组患者穿刺成功率及引流通畅率差异无统计学意义(P>0.05),观察组患者在腹水外渗、疼痛、出血和感染方面的发生率明显减少(P<0.05),观察组患者总有效率为93.8%,高于对照组的78.1%(P<0.05),观察组各生化指标均优于对照组(P<0.05)。结论一次性输血器引流肝硬化顽固性腹水取材方便,操作简单,临床疗效及安全性较高,可有效改善患者生化指标,值得临床推广。
Objective To evaluate the therapeutic value of the disposable blood transfusion device used in refractory ascites in cirrhotic patients.Methods Patients with refractory ascites in 64 cases,were randomly divided into the observation group of 32 cases,32 cases in the control group.The observation group used disposable transfusion puncture drainage of ascites;the control group used the traditional abdominal puncture drainage of ascites.The clinical effects were compared between the two groups after treatment, the clinical index and biochemical index.Results After treatment,two groups of the success rate of puncture and drainage rate had no difference（P 0.05）,but the observation group in the ascites exosmosis, pain,bleeding,infection rate decreased significantly（P 0.05）;observation group,the total efficiency of 93.8%,higher than 78.1% in the control group（P 0.05）,and the observation group each biochemical indicators were superior to the control group（P 0.05）.Conclusions The use of disposable transfusion apparatus drainage of liver cirrhosis with refractory ascites,convenient,simple operation,clinical curative effect and high safety,can effectively improve the biochemical index of patients,is worthy of promotion.
出处
《中国肿瘤临床与康复》
2013年第5期467-469,共3页
Chinese Journal of Clinical Oncology and Rehabilitation
关键词
输血器
顽固性腹水
治疗
Transfusion apparatus Intractable ascites Therapy
